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Abstract 
Aim: The main aim of this study was to review the contemporary use of transvaginal 
cervical cerclage. 
Methods: This retrospective observational study was done at Tygerberg Academic 
Hospital (TBH), a secondary and tertiary referral centre in the Western Cape Province. 
It included all pregnancies in whom a transvaginal cervical cerclage was placed from 
1 Jan 2009 to 31 Dec 2014. Cervical cerclage was deemed successful if pregnancy 
was carried beyond 28 weeks of gestation. 
Results: 140 transvaginal cerclages were identified for analysis, which consisted of 80 
history indicated (HI), 51 ultrasound indicated (UI) and 9 clinical indicated (CI) 
cerclages. An overall success rate of 74.3% was noted, with individual success rates 
of 81.3% and 76.5% in the HI and UI groups respectively. All CI cerclages delivered 
before 28 weeks. The overall live born rate after 24 weeks gestation was 78.6%; 85.0% 
in the HI group, 76.5% in the UI group and 22.2% in the CI group. The preterm birth 
(PTB) rate <34 weeks was 42.6% and 33.3% in the HI and UI groups. Cerclage related 
complications, specifically perioperative rupture of membranes (1.4%), cervical tears 
(2.1%) and suture displacement (5.0%) were infrequently seen, while preterm rupture 
of membranes at any gestation was encountered in 22.1% of all cases.  
Conclusion: Cervical cerclage remains one of the key preventative measures in 
prevention of PTB especially in high risk populations. Our data highlights the diversity 
of patients at risk of PTB and the complexities involved in their care. This study sheds 
light on the need for correct identification of suitable women for cervical cerclage 
insertion in a developing country setting.  
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Opsomming 
Doel: Die hoofdoel van hierdie studie was om die kontemporêre gebruik van 
transvaginale servikale steek te hersien. 
Metodes: Hierdie retrospektiewe waarnemingstudie is by Tygerberg Akademiese 
Hospitaal (TBH), 'n sekondêre en tersiêre verwysingsentrum in die Wes-
Kaapprovinsie, gedoen. Alle swangerskappe is ingesluit in wie 'n transvaginale 
servikale steek van 1 Januarie 2009 tot 31 Desember 2014 geplaas was. ŉ Servikale 
steek is as suksesvol beskou as die swangerskap verby 28 weke volhou. 
Resultate: 140 transvaginale steke is geïdentifiseer vir analise, wat saamgestel is uit 
80 geskiedenis aangeduide (HI), 51 ultraklank aangeduide (UI) en 9 klinies 
aangeduide (CI) steke. Die algehele sukseskoers van 74.3% was waargeneem, met 
individuele sukseskoerse van onderskeidelik 81,3% en 76,5% in die HI- en UI-groepe. 
Al die CI steke is voor 28 weke verlos. Die algehele lewendige geboortekoers, na 24 
weke, was 78,6%, 85,0% in die HI-groep, 76,5% in die UI-groep en 22,2% in die CI-
groep. Die voortydige kraam (PTB)-koers <34 weke, was 42,6% en 33,3% in die HI- 
en UI-groepe. Steek-verwante komplikasies, spesifiek peri-operatiewe ruptuur van 
membrane (1.4%), servikale skeure (2.1%) en steek verplasing (5.0%) was selde 
gesien terwyl premature ruptuur van membrane by enige swangerskapsduur voorkom 
in 22.1% van alle gevalle. 
Gevolgtrekking: Servikale steke bly een van die belangrikste voorkomende maatreëls 
in die voorkoming van PTB, veral in hoërisiko-bevolkings. Ons data beklemtoon die 
omvang van pasiënte wat ŉ risiko het vir PTB en die kompleksiteite wat by hul sorg 
betrokke is. Hierdie studie beklemtoon die behoefte aan korrekte identifisering van 
geskikte vroue vir servikale steke in 'n ontwikkelende land omgewing.  
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Chapter 1: Introduction 
1.1 Background 
Preterm birth (PTB) is estimated to be responsible for 35% of the world’s 3.1 
million annual neonatal deaths1. Complications of PTB are now the second 
most common cause of death after pneumonia in children under 5 years of 
age.1 Furthermore, PTB results in both immediate and long term morbidity in 
the neonate and child.2 Consequently leading to huge socio-economic burdens 
and continued psychosocial and emotional stress on families.3  
Prevention and treatment strategies of PTB have been rather ineffective and 
disappointing. However, one specific aspect of the preterm birth spectrum that 
has a known surgical intervention is cervical incompetence or cervical 
insufficiency as it is sometimes known.4 Cervical incompetence is defined as 
the painless dilation of the cervix during the second trimester of pregnancy 
leading to spontaneous PTB (or late miscarriage) of a live and otherwise 
healthy foetus. Cervical incompetence affects 0.1 – 2.0% of the global obstetric 
population and 8% of women with recurrent 2nd trimester losses.4 In developing 
countries it accounts for up to 15 - 20% of pregnancy losses.5 The mainstay of 
treatment for cervical incompetence is a timely surgical intervention, which 
involves the placement of a surgical suture around the cervix to prevent 
miscarriage or PTB. 
The rates of cervical cerclage placement vary from country to country, with 
some authors reporting that the procedure is more commonly performed in 
developing than developed countries.5 Meta-analyses and systemic reviews on 
cervical cerclage have certainly differed on the effectiveness and benefits of 
this procedure. Data from African-based studies are limited and documented 
outcomes, especially of history-indicated cervical cerclage still need further 
support.6 
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1.2 Problem Statement 
Cervical cerclage efficacy and safety has remained controversial. Multiple 
studies and systemic reviews have been done but with minimal involvement of 
African countries. Therefore, current and good quality data on cervical cerclage 
insertions and outcomes are lacking from South Africa and Africa in particular.  
The aim of this study was to review the contemporary use of transvaginal 
cervical cerclage at Tygerberg Academic Hospital (TBH), which serves as a 
large secondary and tertiary referral centre in Cape Town, Western Cape 
Province, South Africa. Ultimately to compare patient selection, management 
and outcomes to international literature, with the hope of improving the 
provision of evidence-based cervical cerclage in the local population. These 
results could then be extrapolated to other similar African settings. 
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Chapter 2: Literature Review 
2.1 Context of preterm birth 
The cervix plays a critical role in a successful pregnancy. Broadly speaking the 
cervix helps contain the pregnancy within the uterus until the end of gestation. 
Thereafter it must undergo significant changes that allow the safe delivery of 
the baby during labour. The inability to perform the first function can result in a 
late miscarriage or PTB.7 
PTB, defined as delivery of a fetus before 37 weeks of pregnancy, occurs in 
9.6% pregnancies according to the World Health Organisation’s 2005 report. 
This translated into approximately 13 million preterm births worldwide, with 
Africa and Asia accounting for over three quarters of these births.8 The 
importance of PTB is that it contributes to up to 14.1% of perinatal mortality 
worldwide.2  Those premature babies that survive are at risk of developing 
spastic cerebral palsy, cognitive, behavioural, attention and socialisation 
defects, chronic lung disease, vision disturbance and hearing loss.9 Such 
impediments result in multiple hospital visits and admissions with significant 
psychosocial and emotional consequences that impact the individual and their 
families. Such consequences have both short and long-term health service cost 
implications.  
 
Despite the mortality, morbidity and psychosocial impact of PTB, preterm labour 
has remained a poorly understood and complicated syndrome. PTB may either 
be spontaneous or iatrogenic when a woman is electively delivered. 
Spontaneous PTB can be as a result of maternal or fetal causes or a 
combination of them both. However, in the majority of spontaneous cases the 
cause is unknown or idiopathic. Maternal conditions that may lead to PTB 
include hypertensive disorders, autoimmune conditions like systemic lupus, 
diabetes mellitus, smoking, as well as maternal infections such as malaria, 
urinary tract infections, or intrauterine infections. Furthermore, uterine 
anomalies, cervical incompetence, polyhydraminos, immunological factors may 
also play a role while fetal anomalies itself can play a role in preterm labour and 
birth. 
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As noted in the wide range of the above causative elements many factors are 
known to influence the dynamic structure and function of the cervix. These 
factors may differ between patients as well as different pregnancies of the same 
patient. This complex and poorly understood pathophysiology has made the 
identification and formulation of effective prevention strategies difficult. 
However, there is one component with a known preventive strategy that has 
been identified within the complex spectrum of preterm labour, namely cervical 
incompetence also known as cervical insufficiency. 
 
2.2 Cervical incompetence  
The term cervical incompetence was first described as early as 1865 in the 
Lancet. However, it was only in the 1955 when Shirodkar described the interval 
repair of anatomical cervical defects associated with the obstetric history of 
recurrent spontaneous mid-trimester births that the concept was widely 
accepted.10 
 
Cervical incompetence is a clinical diagnosis, and is mostly made 
retrospectively. Its definition varies but there are two widely accepted 
definitions. The first one defines cervical incompetence as the inability of the 
uterus to retain a pregnancy in the absence of signs and symptoms of clinical 
contractions or labour or both in the second trimester of pregnancy.11 The 
second definition involves both clinical and physical components, namely “the 
painless dilatation of the cervix resulting in rupture of membranes and mid-
trimester miscarriage (12 - 24 weeks) and the passage without resistance, of 
size 9 Hegar dilators (9mm), through the cervix in the non-pregnant state.12 The 
latter finding is no longer regarded as reliable. Although an ultrasound finding 
of a short cervical length in the second trimester of pregnancy can be used as 
a tool to aid in the diagnosis of cervical incompetence in some cases, this is not 
an acceptable sole criterion for the definition. Therefore, the diagnosis of 
cervical incompetence comprises a historical component, namely the history of 
a painless cervical dilatation with preterm mid-trimester loss or preterm delivery, 
and/or the combination of physical findings of cervical shortening and dilatation 
during digital cervical examinations, and/or findings of a short cervix during mid-
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trimester sonography in women with the relevant history of spontaneous PTB 
or a combination of all three. 
There are two main theories that identify the pathophysiology of cervical 
incompetence in preterm labour. The first theory is that cervical incompetence 
results in the loss or compromise of the mucus plug resulting in the ascending 
of vaginal infection that can result in PTB.13 The second proposed model 
suggests that cervical incompetence is a continuum that is a consequence of 
premature cervical ripening (in absence of clinical labour) caused by one or 
more underlying factors including infection, local inflammation, hormonal 
effects, or genetic predisposition. These factors may be superimposed on a 
cervix with compromised mechanical integrity, and by means of the 
inflammatory cascade may also present as part of the preterm labour 
syndrome.14  Epidemiological and historical factors have been identified for 
cervical incompetence. These include prior cervical surgery such as cone 
biopsy, large loop excision of the transformation zone, trachelectomy, in utero 
exposure to diethylstilboestrol (DES), prior induced or spontaneous first- and 
second-trimester miscarriages (including dilatation and instrumentation of the 
cervix), uterine anomalies, multiple gestations and prior spontaneous PTBs. 
 
The incidence of cervical incompetence is approximately 1 - 2% of the global 
obstetric population and 8% of women with recurrent second trimester losses.4 
The incidence differs in different countries and even in different hospitals within 
the same country due to population and ethnic differences, variable diagnostic 
criteria, and reporting bias. However, although certain authors state that the 
incidence of cervical incompetence is much higher in women of African origin 
and in developing African countries5, the actual figures remain largely unknown 
due to poor documentation, differences in diagnostic criteria and scarce 
research in these countries. 
 
2.3 Evidence for cervical cerclage 
The mainstay of treatment for cervical incompetence is a surgical procedure, 
namely cervical cerclage. This entails the placement of a surgical suture around 
the cervix as close as possible to the level of the internal cervical os. The 
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procedure is performed at a gestational age of 14 - 24 weeks gestational age 
(GA) via either a transvaginal or transabdominal route. The ideal timing varies 
according to the specific type of procedure and in some cases, is even 
considered prenatally. It is believed that the cervical cerclage helps to prevent 
the loss of the cervical mucus plug, which prevents the ascension of 
microorganisms in the cervical canal in addition to providing mechanical 
support. The suture is usually removed at 37 weeks of gestation in the absence 
of contraindications. However, in some cases it is left in-situ when a caesarean 
delivery is performed and the cerclage (typically of the transabdominal type) is 
retained for the next pregnancy. 
 
The original method described in 1955 by Shirodkar was an interval repair of 
anatomical cervical defects associated with the obstetric history of recurrent 
spontaneous mid-trimester birth that was a particularly invasive vaginal 
procedure.10 Another widely accepted and less invasive procedure was 
described by McDonald in 1957.15 These two procedures have not been 
compared directly and because the latter procedure is less invasive and vaginal 
delivery more easily accomplished, it is currently the more favoured method.16 
There are three main indications for the placement of a cervical cerclage 
namely, history indicated (HI), ultrasound indicated (UI) and rescue or clinical 
indicated (CI) cerclage.  
 
2.3.1. History indicated cerclage 
HI cerclage is usually offered to a woman with three consecutive second 
trimester losses that have a typical history of cervical incompetence, namely 
spontaneous painless fast miscarriage in absence of labour or other known 
causes.17 The final report of the Royal College of Obstetricians and 
Gynaecologists multicentre randomised trial of cervical cerclage also showed 
benefit in “women with a history of three or more spontaneous preterm births.”17 
It is important to rule out other causes of PTB or second trimester loss, through 
a detailed history and physical examination prior to offering a history indicated 
cervical cerclage.  
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HI cervical cerclage is ideally placed electively at 13 - 14 weeks of gestation. 
There are no recent randomised controlled clinical trials that have reported the 
efficacy of HI cerclage. The three main trials that have reported on the 
effectiveness of this procedure are now regarded as “older” studies. The largest 
trial on HI cervical cerclage was the MRC/RCOG Working Party on Cervical 
Cerclage. This study recruited women at risk of preterm delivery from multiple 
international centres based on their history but whose obstetricians were 
unsure of the diagnosis of cervical incompetence. A total of 1292 women were 
randomised to either receive a cervical cerclage or not. In this trial, cerclage 
was regarded as successful if the pregnancy reached 33 weeks’ gestation. 
Results showed fewer deliveries before 33 weeks in the cerclage group (83 of 
647) 15%, compared to the control group 32%, (RR 0.46 95% CI 0.22-0.98). 
However, further statistical analysis revealed that the results were mainly 
influenced by a subset of 107 women who had a history of three or more second 
trimester losses. Removal of this subset nullified the difference between the two 
groups. This data thus supports the use of cervical cerclage in women with a 
history of three consecutive second trimester losses. 
 
The other 2 trials showed no significant benefit with the use of cervical cerclage 
based on history alone.18,19 In both studies women with moderate and high risk 
(30%) of having a late miscarriage or preterm delivery were randomly allocated 
to cerclage insertion. The results showed no difference gestational age of 
delivery or survival. Although the cerclage group had multiple hospital 
admissions and prolonged hospital stay with an increase in tocolytic drug use, 
puerperal sepsis, caesarean section and ultimately preterm deliveries in the 
cerclage group. Though this was not statistically significant as numbers were 
small.  
 
Overall the evidence for HI cerclage is less robust than that currently available 
for UI cerclage procedures. 
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2.3.2. Ultrasound indicated cerclage 
Cervical screening using transvaginal ultrasound for the prediction of preterm 
labour in women with a positive history has become a safe gold standard. This 
accolade presupposes that it is performed correctly.20 Evidence to support the 
use of transvaginal ultrasound to predict preterm labour risk in these women 
was provided in the blinded observational study by Owen et al., in 2001.21 This 
study found that women with a previous spontaneous PTB <32 weeks, with 
cervical lengths <25mm in the current singleton pregnancy had a relative risk 
of spontaneous PTB before 35 weeks of 4.5 (95% CI 2.7-7.6). This threshold 
of <25 mm had a sensitivity of 69%, specificity of 80% and positive predictive 
value of PTB of 55%. It is now widely accepted that cervical length assessment 
in this group of women can be used as a surrogate of cervical incompetence at 
appropriate gestations. On the other hand, in low risk women without a prior 
history of PTB where an incidental finding of a short cervix (<25mm) at 16 - 23 
week scan was noted only 17% ended up with a PTB <32 weeks.17 The use of 
cervical cerclage in this group had no effect on the reduction of PTB.17 It has 
been shown that a short cervix <15mm does predict a high risk of PTB but it 
means screening over 100 women to find 1 case in a low risk population.22 
Therefore, in low risk groups, transvaginal cervical ultrasound assessment is 
still not regarded as an effective screening tool. In addition, funnelling of the 
cervix does not predict or add to the prediction of PTB.23 
 
A recent meta-analysis on UI cervical cerclage involved five randomised, 
controlled trials incorporating over 500 women. UI cerclage achieved a 
decrease in the rate of PTB by 30% and composite perinatal morbidity and 
mortality by 36% compared with the non-cerclage group. There also a decrease 
in previable PTB <24 weeks and perinatal mortality.24 In another meta-analysis 
of trials using individual patient–level data, with the incidental finding of a short 
cervix of <25 mm between 16 and 24 weeks of gestation without prior history 
of PTB, cervical cerclage placement did not decrease the rate of PTB.25,26 In 
addition, in women with other risk factors for PTB, such as cone biopsy, DES 
exposure, dilation and curettage, who were randomised to cerclage vs no 
cerclage after cervical screening and findings of cervical length of <25 mm, 
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cerclage placement did not show a decrease in PTB.27.Therefore, ultrasound 
indicated cerclage is reserved for cases with a cervical measurement of 
<25mm, with or without funnelling, before a gestational age of 24 weeks in 
women who are undergoing cervical length screening due to a prior history of 
spontaneous PTB between 16 - 24 weeks gestation. This group may also be a 
target for progesterone therapy which will be briefly discussed later. 
 
2.3.3. Clinically indicated (emergency, rescue) cerclage 
Clinically or physical examination indicated cerclage is the placement of 
cervical cerclage in women in the second trimester who present with cervical 
dilatation in absence of labour, and placental abruption. Although controversial, 
when inserted in correctly selected cases the overviews show greater benefit 
than harm. To date there is only one randomised controlled trial for this 
indication, but it was small with a total of 27 women including seven sets of 
twins.28 
  
There has been a recent systematic review and meta-analysis of CI cerclage 
that included ten studies (aforementioned one small randomised control trial, 
two prospective cohorts and seven retrospective groups).28 This analysis 
studied women between 14 - 27 weeks’ gestation with a minimum cervical 
dilatation of 0.5cm. It included a total of 757 women. The primary outcome of 
neonatal survival was higher in the cerclage group vs control group. There was 
a significant prolongation of pregnancy (mean difference 34 days), and a 
greater gestational age at delivery (mean difference 32 days), with reduced 
PTB between 24 - 28 weeks (8% compared to 37%) and PTB less than 34 
weeks of gestation (50% compared to 82%). However, there was no difference 
in PTB under 24 weeks. It must be appreciated that the studies included in this 
systematic review were limited in size and had variable quality and study 
design. Overall there is weak positive evidence that CI cerclage is effective in 
reduction of PTB. Therefore, large well designed randomised trials, providing 
good quality evidence are still required. 
Of concern is that CI cerclage may prolong pregnancy only to advance 
previable pregnancies to extremely preterm deliveries with their high rates of 
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complications of prematurity. However, these women usually enter pregnancy 
with high risks for PTB and clinicians will work hard to simply achieve the 
threshold of viability. There may be clinician bias in the decision whether to 
place a cerclage based on the clinician’s own interpretation of the possible 
success of that cerclage. In the analysis by Ehsanipoor et al., several risk 
factors were identified that influenced the outcome of CI cervical cerclage, 
namely cervical dilatation, membrane prolapse, obstetric history, evidence of 
infection.28  
 
2.4 Cerclage under special circumstances 
2.4.1. Transabdominal cerclage 
This cerclage is placed in women with poor obstetric history where transvaginal 
cerclage has failed, the cervix is very short (e.g. after recurrent cone biopsies) 
or has significant damage such as deep tears. Transabdominal cerclage 
involves the insertion of the cerclage internally at the upper level of the cervical 
canal. The procedure may be performed openly or laparoscopically. The timing 
in open surgery is usually restricted to a gestation window from 12 - 14 weeks 
(thereby allowing for spontaneous first trimester miscarriage) but laparoscopic 
procedures are often performed prior to pregnancy. The success rates in 
reported case series are very high (85 - 90%).29 However, the morbidity 
(especially haemorrhage) associated with this procedure needs to be carefully 
considered. 
 
2.4.2. Cerclage in multiple gestation 
Twin gestations have a higher risk of PTB compared to singleton pregnancy. 
However, unlike singleton pregnancy the use of cervical cerclage in an 
asymptomatic twin pregnancy with a short cervix < 25mm before 24 weeks does 
not prevent PTB and may increase the risk for harm. This position is supported 
by the recent Cochrane review30 and another large meta-analysis25. These 
reviews showed associated worse neonatal outcomes with delivery up to four 
weeks earlier compared to controls. However, these outcomes were not 
adjusted for confounders of demographic characteristics, risk factors and 
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indication for cervical cerclage. This prompted a recent meta-analysis where 
the outcomes were adjusted for such confounding variables and results were 
reported using a random effects model.31 These results showed no benefit or 
harm from cervical cerclage compared to controls, with the rate of very low birth 
weight and respiratory distress syndrome being higher in the cerclage group 
compared to the control group with borderline significance.  
 
In conclusion, there is currently no role in the use of cervical cerclage in 
asymptomatic twins with short cervix <25 mm on transvaginal ultrasound. 
 
2.4.3. Cerclage and PPROM 
Insertion of cervical cerclage with preterm prelabour rupture of membranes 
(PPROM) is not recommended. Additionally, there is insufficient evidence for 
the removal of cervical cerclage upon immediate diagnosis of PPROM or even 
within 24 hours after administration of steroids. Although it has been shown that 
retention of cervical cerclage for more than 24 hours after PPROM has been 
shown to prolong pregnancy there is also an increased risk of infection for both 
the mother and neonate.32 Individualisation of specific case circumstances 
should be applied, but cerclage removal is generally recommended either 
immediately after diagnosis or following the administration of corticosteroids 
(i.e. after about 48 hours). 
 
2.4.4. Cervical Cerclage in African countries 
The prevalence of cervical incompetence in African populations remains 
unknown. The PRAM study showed a prevalence of cervical incompetence of 
5.3% in black Hispanics and 4.1% in American Whites.33 Another study 
reported the incidence of PTB to be higher in women of African origin living in 
America34. However, these results cannot be extrapolated to African countries 
as demographic, behavioural and environmental factors are certainly different. 
Although it can be speculated that the rate of cervical incompetence is higher 
in African countries there are no robust data to support this. 
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Very few studies have been done exclusively in African countries, with most 
studies involving African countries as part of international multicentre trials.17 35 
Studies performed exclusively in single African locations have taken the form 
of retrospective audits on the use of cervical cerclage in single units with small 
numbers.5,36 An example of the above is a retrospective observational study of 
199 patients performed in Kenya.5 Most women in this study received a HI 
cervical cerclage for cervical incompetence and the majority (66%) did not have 
any ultrasound examination. Of the 34% that had an ultrasound scan, only 7.8% 
received a transvaginal ultrasound cervical length assessment. This reflects 
one of the challenges faced by developing African countries.  
 
Two studies on cervical cerclage have been performed in South Africa.19,17 One 
which is now more than 30 years old, was a randomised controlled trial for HI 
cerclage which was performed exclusively in this country19. The other was part 
of a multinational study.17 
 
Contextually, the majority of the women included in African studies were of low 
economic status. These women often suffered more than the required number 
of pregnancy losses before a diagnosis of cervical incompetence is made, due 
to poorly functioning health care systems and under reporting by patients. In 
addition, low socio-economic status is associated with high risk infection 
profiles. This concurs with other studies in that low social and economic status 
seem to be stronger determinants of poor pregnancy outcome than actual 
ethnicity.37 In addition, few women (8%) who received cervical cerclage 
underwent gold standard, transvaginal ultrasound cervical assessment.5 This 
means that too few high-risk women receive appropriate screening for cervical 
incompetence. It is concerning that in these studies the majority of women who 
underwent “history indicated cerclage” did not have a complete work up to rule 
out other causes of second trimester losses. This could be attributed to poor 
clinical skills, record keeping and the lack of available, appropriate diagnostic 
equipment. 
 
Alternative PTB prevention strategies such as progesterone are not available 
in most public hospitals in African countries due to financial constraints. Overall 
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the diagnosis and management of cervical incompetence in African countries 
is negatively influenced by the financial situation and poor health systems. 
 
2.5 Other interventions for the prevention of PTB 
Progesterone - There is good evidence for use of progesterone beginning at 
16-20 weeks until 36 weeks, in women with previous PTB38. Vaginal 
progesterone suppositories have been shown to reduce PTB and perinatal 
morbidity and mortality.39 There is weak evidence for the use of progesterone 
in women with no prior history of PTB with a short cervix <20mm at < 24 weeks 
identified during transvaginal ultrasound. Progesterone is not clearly effective 
in twin gestations, preterm labour or PPROM.40 
 
Cervical pessary - Cervical pessaries have been compared to cervical cerclage 
with favourable effect in small studies41, but this benefit has seemed elusive in 
larger one42. 
 
Bed rest - Currently there is no evidence that bed rest is beneficial for this 
condition.43  
 
2.6 Conclusion 
From this literature review it is clear that the strongest evidence is for UI 
cerclage in women with prior spontaneous PTB. On the other hand, evidence 
for cervical cerclage placement purely on past obstetric history is less robust 
with effectiveness seen only in a subset of women with three or more 
consecutive PTBs or second trimester losses. Finally, there is weak positive 
evidence that CI cerclage is effective in reduction of PTB. Although the use for 
vaginal progesterone is emerging to be just as effective as cervical cerclage 
insertion in women with previous preterm birth33, its lack of availability in 
developing countries makes it a limited option. 
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Chapter 3: Methods 
3.3 Research Design  
3.3.1. Type of study 
This was a retrospective observational study 
3.3.2. Study setting 
Tygerberg Academic Hospital (TBH), a secondary and tertiary referral centre in 
the Western Cape Province responsible for the Metro East region of Cape Town 
and designated rural areas. Tygerberg Hospital is a tertiary hospital located in 
Parow, Cape Town. The hospital is the largest hospital in the Western Cape 
and the second largest hospital in South Africa. It acts as a teaching hospital in 
conjunction with the University of Stellenbosch’s Health Sciences Faculty, 
serving the Metro East region of Cape Town. It has a catchment population of 
over 2.6 million. 
3.3.3. Study Subjects 
We included all pregnancies in whom a transvaginal cervical cerclage was 
placed from 1 Jan 2009 to 31 Dec 2014. Patients were identified from the 
obstetrics theatre lists. Women who have had a transvaginal cervical cerclage 
inserted outside Tygerberg hospital but delivered at this institution were 
excluded. 
 
3.4 Data collection 
The principal investigator (PI) extracted data from the files to complete a coded 
data sheet (Appendix 1) reflecting no patient identifiable information. This data 
was loaded onto a Microsoft Excel database in strictly anonymous fashion.  
 
3.5 Outcome measures 
3.5.1. Primary outcome measures 
 Gestational age at delivery (delivery before 28 and 34 weeks of 
gestation) 
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 Live born rate defined as number of deliveries that result in a live 
neonate at time of discharge. 
3.5.2. Secondary outcomes 
 Cerclage specific outcomes: indication and incidence of cervical 
cerclage placement, cerclage interval duration and cerclage specific 
complications. 
 Maternal morbidity outcomes: miscarriage (defined as pregnancy loss 
before 24 weeks of gestation), preterm labour (defined as regular uterine 
contractions resulting in cervical changes before 37 weeks of 
pregnancy), preterm rupture of membranes (defined as rupture of 
membranes before 37 weeks of pregnancy), mode of delivery. 
 Neonatal morbidity outcomes – birth weight (weight below 2000g and 
below 1500g), duration of neonatal hospital stay, composite neonatal 
morbidity score (including FSB, ENND, 5min APGAR <7, admission to 
NICU). 
 
3.6 Ethics 
The protocol was submitted for local ethical review and was approved by the 
Health Research Ethics Committee of Stellenbosch University (S14/09/179) to 
conduct this anonymised audit. 
 
3.7 Data analysis and statistical methods 
Data was collected and analysed in Statistic version 12 (2014). For descriptive 
statistics, first data was checked for normality of distribution using a 
Kolmogorov-Smirnov test. Continuous variables were expressed as means and 
standard deviations if normally distributed and medians and interquartile ranges 
(IQRs) if the data was non-normally distributed. For ordinal variables medians 
and interquartile ranges (IQRs) if data are non-normally distributed. For nominal 
variables, data was presented using frequency distributions with graphical 
presentation will be by means of bar charts and 95% confidence for binary 
proportions were presented. 
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A multivariate linear regression analysis was used to define the cerclage 
interval relationship between the groups and defined co-variables (age, BMI, 
gravidity, parity, previous obstetric history, cervical assessment, case 
assessment, gestational age at insertion, primary surgeon and suture material 
used). A 5% significance level will be applied throughout for all analyses. 
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Chapter 4: Results 
4.1 Baseline population characteristics 
A total of 154 transvaginal cerclages were identified from the Tygerberg 
Hospital surgical records from the period of January 2009 to December 2014. 
Fourteen cases were excluded due to missing clinical records. Another 22 
records were incomplete but they were still included in the final analysis of the 
remaining 140 cases. A total of 80 history indicated (HI), 51 ultrasound 
indicated (UI) and 9 clinical examination indicated (CI) transvaginal cerclages 
were analysed.  
The baseline population characteristics are depicted in Table 1. Social drug 
use was common in this population with 28.6% (40/140) admitting to smoking, 
20% (28/140) to alcohol use, and 1.4% (2/140) to methamphetamine use. The 
women in the CI group were older, more obese and had a higher incidence of 
smoking making it a particularly high-risk group.  
 
Table 1: Patient demographic data 
 
 
History 
Indicated 
N=80 
Ultrasound 
Indicated 
N=51 
Clinical 
Indicated 
N=9 
All 
N=140 
Age (years)* 30±6 31±5 32±5 30±5 
Gravidity # 5 (1-7) 5 (1-8) 5 (1-9) 5 (1-9) 
Parity # 1 (0-5) 2 (0-6) 0 (0-3) 1 (1-6) 
BMI ≥ 30 kg/m2 ‡ 28 (35.0%) 6 (11.8%) 6 (66.7%) 40 (28.6%) 
Syphilis – positive Rapid 
Plasma Reagin test ‡ 
5 (6.3%) 3 (5.9%) - 8 (5.7%) 
HIV Positive on PMTCT ‡ 5 (6.3%) 2 (3.9%) 1 (11.1%) 8 (5.7%) 
HIV Positive on HAART ‡ 4 (5.0%) 3 (5.9%) - 7 (5.0%) 
Smoking ‡ 21 (26.3%) 15 (29.4%) 4 (44. 4%) 40 (28.6%) 
* Mean ± SD; # Median (Range); ‡ n (%)  
BMI - body mass index; HIV - Human Immunodeficiency Virus; HAART - Highly Active Antiretroviral 
Treatment; PMTCT - Prevention Mother to Child Transmission 
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4.2 Medical and surgical history 
The study population medical history profile mimics that of a high-risk group 
with 1 in 4 women having a pre-existing medical disorder, specifically 
hypertension (12.1%) and diabetes mellitus (4.3%).  
A history of Large Loop Excision of the Transformation Zone (LLETZ) was 
noted in 5.8% of the patients. One case belonging to the HI group, a deep 
cervical tear was noted at time of cerclage placement. She had a history of 
three second trimester losses intermixed with 2 preterm deliveries and in this 
index pregnancy she unfortunately miscarried at 21w. She was offered a TAC 
in her next pregnancy.  
  The past medical and surgical history is depicted in Table 2.  
 
Table 2: Medical and surgical history 
 
 
History 
Indicated 
N=80 
Ultrasound 
Indicated 
N=51 
Clinical 
Indicated 
N=9 
All 
N=140 
Medical History 
Hypertension 8 (10.0%) 8 (15.7%) 1 (11.1%) 17 (12.1%) 
Diabetes 5 (6.3%) 1 (2.0%) - 6 (4.3%) 
Asthma 3 (3.8%) 2 (3.9%) 1 (11.1%) 6 (4.3%) 
Other chronic medical 
conditions* 
1 (1.3%) 5 (9.8%) 1 (11.1%) 7 (5.0%) 
Surgical history 
Previous caesarean deliveries 9 (11.3%) 6 (11.8%) 1 (11%) 16 (11.4%) 
Gynaecological surgery - 3 (5.9%) - 3 (2.1%) 
Large Loop Excision of the 
Transformation Zone 
4 (5.0%) 3 (5.9%) - 8 (5.7%) 
Data presented as n (%) 
*other medical conditions included: chronic cystitis, pneumonia, pyelonephritis 
 
4.3 Obstetric history 
Reviewing the past obstetric history of this cohort, it was noted that 2.9% 
(4/140) had a previous hypertensive disorder in pregnancy with 1.4% (2/140) 
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having a pregnancy complicated by a placenta abruption. In 3.6% (5/140) of the 
cases a uterine curettage post miscarriage was done. The past obstetric history 
concerning miscarriages and PTB are captured in Table 3. Of those with T2 
miscarriages, 17.8% (21/118) were deemed to have clear history of a fast and 
painless miscarriage. Out of the 39 patients who had one previously placed 
cervical cerclage, 71.8% were successful. In the 18 cases with more than one 
prior cervical cerclages placement, 66.7% of these were successful. 
 
Table 3: Miscarriage, preterm birth and cervical cerclage history  
 
History 
Indicated 
N=80 
Ultrasound 
Indicated 
N=51 
Clinical 
Indicated 
N=9 
All 
N=140 
TI miscarriage (<13w0d) 
 Once 
 Twice 
 ≥ 3 
20 (25.0%) 
6 (7.5%) 
2 (2.5%) 
 
16 (31,4%) 
2 (3.9%) 
3 (5.9%) 
 
- 
2 (22.2%) 
2 (22.2%) 
 
36 (25.7%) 
10 (7.1%) 
7 (5.0%) 
T2 miscarriage (13w0d -23w6d) 
 Once 
 Twice 
 ≥ 3 
 Spontaneous, painless ≥2 
 Spontaneous, painless ≥3 
8 (10.0%) 
31 (38.8%) 
33 (41.3%) 
30 (37.5%) 
16 (20.0%) 
 
15 (29.4%) 
17 (33.3% 
9 (17.6%) 
12 (23.5%) 
4 (7.8%) 
 
- 
2 (22.2%) 
3 (33.3%) 
1 (11.1%) 
1 (11.1%) 
 
23 (16.4%) 
50 (35.7%) 
45 (32.1%) 
43 (30.7%) 
21 (15.0%) 
Preterm birth 24w0d-27w6d 26 (32.5%) 19 (37.3%) 3 (33.3%) 48 (34.3%) 
Preterm birth 28w0d-33w6d 17 (21.3%) 16 (31.4%) 2 (22.2%) 35 (25.0%) 
Preterm birth 34w0d-36w6d 7 (8.8%) 2 (3.9%) - 9 (6.4%) 
Previous cerclage 
 1 
 ≥2 
27 (33.8%) 
10 (12.5%) 
 
10 (19.6%) 
7 (13.7%) 
 
2 (22, 2%) 
1 (11.1%) 
 
39 (27.9%) 
18 (12.9%) 
Success 
 1 
 ≥2 
 
19 /27 (70%) 
8/10(80%) 
 
8 /10 (80%) 
4/7 (57%) 
 
1/2 (50.0%) 
- 
 
28/39 (71.8%) 
12/18 (66.7%) 
Data presented as n (%) 
 
4.4 Indication and placement of cervical cerclages 
During selection of the cases just over half of the women 57.1% (80/140) had 
a Nuchal Translucency (NT) screening scan. 2 screened high risk due to an NT 
measurement above the P95, one belonging to the HI and one to the UI group.  
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Both opted for no further invasive testing and had normal structural review 
ultrasounds at 20 weeks, both babies were phenotypically normal at birth.  
Of the 87.1% (122/140) who had a mid-trimester anomaly scan, 7 screened 
high risk (2 in HI group, 4 UI group, 1 CI group). This was due to soft markers 
in 6 cases, 5 delivered phenotypical normal babies and in one case the 
outcome is unknown. The seventh case had a HI cerclage placed at 14 weeks, 
invasive testing was performed due to multiple major structural anomalies 
detected at 19 weeks gestation. Karyotyping in this case revealed T18 and a 
termination of pregnancy was subsequently performed.  
Almost all cases 96.4% (135/140) had midstream urine sent for microscopy and 
culture, wherein 15.7% (22/140) had a positive culture and were treated, 13 
from the HI group, 8 from the UI and 1 from the CI group. 
Sonographic and clinical evaluation of the cervices is depicted in Table 4. 
 
Table 4: Cervical screening parameters 
 
History 
Indicated 
N=80 
Ultrasound 
Indicated 
N=51 
Clinical 
Indicated 
N=9 
Total 
N=140 
TVU Cervical length (mm) # 25 (10-45) 15 (3-25) 7 (0-38) 15 (0-45) 
Cervical tear/trauma on 
clinical assessment 
12 (15.0%) 7 (13.7%) - 19 (13%) 
Cervical portio on clinical 
assessment (mm)  # 
15 (0-41) 15 (0-25) 8 (0-15) 15 (0-41) 
Cervical dilatation on 
clinical assessment (mm) # 
- 0 (0-25) 20 (10-25) 0 (0-25) 
Bacterial vaginosis 2 (2.5%) 5 (9.8%) - 7 (5.0%) 
Trichomonas vaginalis 4 (5.0%) - - 4 (2.9%) 
Candidiasis 6 (7.5%) 1 (2.0%) - 7 (5.0%) 
*# Median (Range) or n (%) 
TVU – transvaginal ultrasound 
 
The indications by the attending doctor and final indications for the cervical 
cerclage insertion after reviewing all the medical records are depicted in Figure 1. 
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In the HI group, where women were selected purely based upon their past 
obstetric history, 51.3% (41/80) of the cases had a classical history of cervical 
insufficiency. All the UI cerclages insertions were based upon a shortening cervical 
length (25mm or less) on serial transvaginal ultrasonography. One case in this 
group progressed to clinically dilatation by the time the cerclage was being placed. 
In this case, there was a discrepancy between cervical length at screening which 
was 25mm with a closed cervical os and the intraoperative clinical findings of clear 
cervical dilatation of 25mm. Of note there was a 5-day interval from the initial 
screening to placement due to the unavailability of theatre lists, yet she delivered 
at term after elective cerclage removal at 37w. 
 
Figure 1: Case assessment and final indication 
 
*Recurrent miscarriages – repetitive (not necessary consecutive) first trimester miscarriages; Recurrent 
(not necessary consecutive) mid-trimester losses – GA 13w0d – 23w6d; Cervical incompetence – 
consecutive recurrent spontaneous painless mid trimester losses 3; TVUCL – transvaginal ultrasound 
cervical length less than 25mm; Clinical incompetence – clinical painless cervical dilatation 
 
As part of preoperative management, the majority of the patients received 
antibiotics [77.5% (62/80) in the HI group, 82.4% (42/51) in the UI group and 
66.7% (6/9) in the CI], of which intravenous antibiotics were given to 43.8% 
(35/80), 56.9% (29/51) and 66.7% (6/9) in the HI, UI and CI cases respectively. 
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Additionally, perioperative indomethacin was given to  90.0% (72/80) of the HI, in 
86.3% (44/51) of the UI and in 66.7% (6/9) of the CI cases. 
 
All cerclages were placed under spinal anaesthesia except for 2.5% (2/81) of HI 
and 2.0% (1/51) of the UI cases. In these three cases, general anaesthesia was 
administered after numerous failed spinal attempts. Unfortunately, the anaesthetic 
notes on these 3 cases were not clear and no definitive reason for the inability to 
place a spinal anaesthesia was given. The primary surgeon involved in placing the 
cerclage is depicted in Figure 2. 
 
Figure 2: Primary surgeon involved 
 
Numbers of cases in each group depicted as a percentage stacked bar chart.  
*Maternal-Fetal specialist – subspecialty of Obstetrics; Obstetrician and Gynaecologist – qualified 
specialist; Senior registrar – year 3 and 4 residency in Obstetrics and Gynaecology; Junior registrar – 
year 1 and 2 residency in Obstetrics and Gynaecology; Medical officer - qualified medical doctor working 
in Obstetrics and Gynaecology department 
 
The median duration of surgery time was 19 minutes (5 – 65 minutes) and did not 
differ significantly between the groups (HI 15 minutes (5 – 65 minutes), UI 17 
minutes (10 – 45 minutes), CI 20 minutes (10 – 35 minutes).  
 
Hospital stay duration was similar between the groups with almost all women 
being discharged by day 2 postoperative. The median hospital stay was one day 
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(0 - 5 days) in the HI, one day (0 - 5 days) in the UI and one day (1 - 17 days) in 
the CI group. In the HI group one women remained in hospital for 5 days due to 
persistent mild vaginal bleeding but was discharged subsequently. Similarly, one 
women in the UI group had a very challenging cerclage placement at 14 weeks. It 
was complicated by vaginal bleeding and rupture of membranes and she stayed 
in hospital for 5 days. The suture was left in place and she ultimately delivered at 
29 weeks. The longest hospital stays of 17 days belongs to a woman in the CI 
group. She was hospitalised for a total of 17 days due to persistent per vaginal 
bleeding after cerclage placement at 23 weeks, followed by rupture of membranes 
on the 4th postoperative day. She remained in hospital and the cerclage was only 
removed at 25w3d after the onset of mild contractions. In this case the patient 
chose to be expectantly managed, remained in hospital ultimately delivering 
spontaneously at 26w. 
 
4.5 Cerclage specific and antenatal outcomes 
The median gestational age of cervical cerclage insertion was 108 days (57-151), 
136 days (96-161) and 145 days (100-166) respectively for HI, UI and CI groups. 
While the median gestation of removal was 237 (112-279), 246 (112-274) and 164 
(101-183) days respectively. The stich intervals of each group are depicted in a 
survival plot in Figure 3a. This is not seen as a true comparison between the 
groups since the gestational age at insertion plays a key role in interpretation of 
the cerclage interval. Therefore, in Figure 3b the cerclage interval is depicted with 
the true GA depicted on the x axis. The median stitch intervals per group were 134 
(25-197), 114 (13-173) and 16 (10-35) days respectively for the HI, UI and CI 
groups. To define which antenatal and surgical variables are most predictive of the 
cerclage success i.e. cerclage interval, a univariate general linear regression 
model was performed and only the GA at insertion proven to be predictive. 
Consequently, if the cerclage interval is corrected for the GA at insertion then there 
is no difference in the cerclage interval between the HI and UI groups and a trend 
toward better outcomes in the UI group.  
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Figure 3: Cerclage interval as survival analysis plot.  
 
*A-survival analysis of cerclage interval between the groups; B-survival analysis between the HI and UI 
groups weighted for gestational age of insertion.  
 
Another key factor in the success of a cerclage is the incidence of cerclage related 
complications and this is depicted with the antenatal obstetric outcomes in Table 5. 
Intraoperative complications were infrequently seen but in roughly 3% of cases a direct 
cervical tear was caused or the membranes ruptured during the cerclage placement. Both 
cases in which a cervical tear occurred in the HI group delivered a live born babies before 
34 weeks GA, while ONR case in the UI group miscarried at 20 weeks. Vaginal bleeding 
after cerclage placement prior to discharge was seen in 3.6% of all women, which was 
mostly mild and all were self-limiting. The main cerclage complication after hospital 
discharge was rupture of membranes, at any gestation before 37 weeks, and was noted 
in 22.1% of the cases. Spontaneous cervical cerclage suture displacement was also seen 
in 5.0% of cases during subsequent antenatal care. Displacement in the HI group occurred 
in three cases, with two cases having a portio vaginalis of 10mm, both delivered live babies 
at 29 and 31 weeks GA. The last case in the HI group had a portio of 15mm but with two 
old lateral cervical tears and she delivered a live born at 27w4d. In the UI group, two cases 
had no visible portio vaginalis and had difficult cerclage placement, they both miscarried 
at 16 and 23 weeks. The last case in the UI group had a portio of 10mm and an 
uncomplicated placement with a live born delivery at 31w. 
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Table 5: Cerclage and antenatal outcomes 
 
 
History 
Indicated 
N=80 
Ultrasound 
Indicated 
N=51 
Clinical 
Indicated 
N=9 
All 
N=140 
Immediate surgical complications (before discharge) (n %) 
Tear 2 (2.5%) 1 (1.9%) - 3 (2.1%) 
Inability to place - 1 (1.9%) - 1 (0.7%) 
Per vaginal bleeding 2 (2.5%) 2 (3.9%) 1 (11.1%) 5 (3.6%) 
Rupture of membranes (within 
72 hours of placement) 
0 1 (1.9%) 1 (11.1%) 2 (1.4%) 
Cerclage complications (after discharge) (n%) 
Displacement 3 (3.8%) 3 (5.9%) 1 (11.1%) 7 (5.0%) 
Rupture of membranes (at any 
gestation) 
16 (20.0%) 12 (23.5%) 3 (33.3%) 31 (22.1%) 
Antenatal complications after 24w (n%) 
Preterm labour 31 (38.8%) 13 (25.5%) 4 (44.0%) 48 (34.3%) 
PPROM 10 (12.5%) 7 (13.7%) 1 (11.1%) 18 (12.9%) 
Antepartum haemorrhage - 2 (3.9 %) 1 (11.1%) 3 (2.1%) 
Gestational hypertension 3 (3.8 %) 2 (3.9 %) - 5 (3.6 %) 
Preeclampsia 4 (5.0%) 5 (9.8%) - 9 (6.4 %) 
Gestational diabetes 6 (7.5 %) 3 (5.9 %) - 9 (6.4%) 
*Displacement - defined as cerclage suture slip from its original insertion around the cervical os or not 
in its place at follow up 
 
There were a total of 63, 36 and 8 antenatal admissions events for the HI, UI and 
CI groups respectively. This was mostly for preterm labour episodes occurring in 
34.3% of all cases. This lead to antenatal tocolysis being given to 23.8% (19/80), 
19.6% (10/51) and 44.4% (4/9) of the HI, UI and CI groups respectively. Antenatal 
corticosteroids were given to 35% (28/80), 35.3% (18/51) and 33.3% (3/9) of the 
HI, UI and CI groups respectively. Beyond the anticipated but remarkably common 
preterm labour and PPROM, gestational hypertensive disorders were seen in 
10.0%. No cases of IUGR/ FGR were detected antenatally in this cohort. 
Preeclampsia was seen in 2 cases <34 weeks gestation, one from the HI group 
and the other from the UI group respectively.  
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The cervical cerclages was removed at a median gestation age of 237 (112-279), 
246 (112-274) and 164 (101-183) days respectively for the HI, UI and CI groups. 
The timing of the removal is depicted in Figure 4.  
 
Figure 4: Timing of cervical cerclage removal  
 
*Numbers per time point of cerclage removal for each group depicted as a percentage stacked bar 
chart.  
 
4.1 Delivery outcomes: 
The median gestation age at delivery was 248 (112-295), 254 (112-288) and 164 
(101-183) days respectively for the HI, UI and CI groups. The delivery outcomes 
are depicted in Table 6. Labour occurred spontaneously in 79.3% (111/140) of all 
cases. However, in 4.3% (6/140) a prelabour caesarean delivery was indicated. 
Indications being hypertensive disorders of pregnancy (n=2), fetal malposition 
(n=2), failed induction of labour (n=2).In addition 10.0% (14/140) of cases an 
induction was required for hypertensive disorders of pregnancy (n=7), gestational 
diabetes (n=2), PPROM (n=2), post term (n=1) and unknown indication in two 
cases. 
One case in the CI cerclages was delivered by Caesarean Section due to fetal 
distress after preterm rupture of membranes at a gestation of 25w6d. 
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Table 6: Delivery outcomes 
 History 
Indicated 
N=80 
Ultrasound 
Indicated 
N=51 
Clinical 
Indicated 
N=9 
All 
N=140 
Gestational age of Delivery (n %) 
 Unknown 3 (3.8%) 2 (3.9%) 1 (11.1%) 6 (4.3%) 
 <24w 9 (11,3%) 7 (13,7%) 4 (44.4%) 20 (14.3%) 
 24-27w6d 3 (3.8%) 3 (5.9%) 4 (44.4%) 10 (7.1%) 
 28-33w6d 22 (27.5%) 7 (13.7%) - 29 (20.7%) 
 34w-36w6d 9 (11.3%) 11 (21.6%) - 20 (14.3 %) 
 37+w 34 (42.5%) 21 (41.2%) - 55 (39.3%) 
Mode of delivery (n %) 
 Unknown 6 (7.5%) 2 (3.9%) 1 (11.1%) 9 (6.4%) 
 Caesarean Section (total) 18 (22.5%) 14 (27.5%) 1 (11.1%) 33 (23.6%) 
 Caesarean Section (elective)  4/18 (22%) 2/14 (14%) - 6/33 (18%) 
 Vaginal delivery  56 (70.0%) 35 (68.6%) 7 (77.8 %) 98 (70.0%) 
 
4.2 Neonatal outcomes 
The overall median delivery gestation was 240 (101-295) days. Each group had 
one neonatal death related to extreme prematurity complications after a 
spontaneous vaginal delivery before 28 weeks gestation. Overall still born rate for 
deliveries after 24 weeks gestation was 2.9%. These were related to a single case 
of abruption placentae at 29 weeks’ GA in the UI group, and three cases of ROM 
at the limits of viability (24w1, 24w3 and 26w1).  
 
Furthermore, there was a fetal loss rate before 24 weeks gestation of 14.3% 
(20/140) resulting in a total perinatal loss rate of 19.3% (27/140). 
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Table 7: Neonatal outcomes: 
 
History 
Indicated 
N=80 
Ultrasound 
Indicated 
N=51 
Clinical 
Indicated 
N=9 
All 
N=140 
Unknown 3 (3.8%) 2 (3.9%) 1 (11.1%) 6 (4.3%) 
Delivery gestation 
(days) 
248 (112-295) 254 (112-288) 164 (101-183) 240 (101-295) 
Live born# 68 (85.0%) 39 (76.5%) 3 (22.2%) 110 (78.6%) 
Fresh Stillbirth# 0 3 (5.9%) 1 (11.1%) 4 (2.9%) 
Early neonatal death# 1 (1.3%) 1 (2.0%) 1 (11.1%) 3 (2.1%) 
Birth weight (g)# 2500 (720-4610) 2535 (600-4080) 710 (630-800) 2460 (630-4610) 
5min Apgar 9 (0-10) 9 (0-10) 0 (0-9) 9 (0-10) 
* Data displayed as median (range) or n (%); # For GA  24w0d 
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Chapter 5: Conclusion 
5.1 Summary of Finding 
In this moderately sized retrospective review of transvaginal cervical cerclage 
insertion 80 HI, 51 UI and 9 CI cerclages were identified over a period of 5 years. 
An overall success rate (i.e. delivery after 28 weeks of gestation) was 781.3% in 
the HI and  76.5%  in the UI groups respectively. Regrettably all CI cerclages 
delivered before 28 weeks. Cervical cerclage insertion lead to an overall live born 
rate after 24 weeks gestation of 78.6%, once again better trends being seen in the 
HI group (85.0%) than the UI group (76.5%). The low live born rate in the CI group 
(22.2%) is mostly related to the extreme preterm delivery gestational age. 
More sombrely cerclage related complications were frequently encountered 
especially displacement of cervical cerclage (5.0%) and rupture of membranes 
after discharge of the patient (22.1%). Moreover, the high rates of PTB of 56.4% 
(before 37 weeks) and 42.1% (before 34 weeks) were difficult to interpret due to 
the high-risk profile of this cohort.  
 
5.2 General Discussion 
Publications on cervical cerclages are rarely uniform in reporting outcomes. This 
makes it particularly difficult to directly compare the outcomes between data sets. 
Most studies report on a PTB rate before 34 weeks44 or 37 weeks gestation45,18 . 
Live born rates were also not consistently reported in all trials. In some trials 
stillbirth and miscarriages were subtracted from the total number randomised to 
the cerclage group to extrapolate live birth rates. In addition, most studies do not 
report on fetal loss alone but rather as a composite perinatal outcome. 
The best comparative evidence for PTB rates for HI is from an old study carried 
out in South Africa by Rush et al.,19 where a total of 194 high risk women were 
enrolled, randomised to cerclage vs. standard care. The cerclage group had a high 
PTB rate less than 37 weeks of 34% which was higher than the control group of 
32%. The first published multicentre study of 506 women at moderate risk of PTB 
(based upon a scoring chart), were randomly allocated to either cervical cerclage 
insertion or standard care.18 Herein the PTB rate, less than 37 weeks, was merely 
6.7% and similar to the 5.5% in their control group. While the only RCT on HI 
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cerclage, was composed of 1292 women whom were randomised to cerclage 
insertion or standard care only if the obstetrician was uncertain of cervical cerclage 
insertion.17 This RCT reported PTB rates <37 weeks of 26% and <34 weeks of 
13% in the cerclage group, and PTB rates <37 weeks of 30% and < 34 weeks of 
18 % in the standard care group. Our study reported a much higher PTB rates in 
the HI group; < 37 weeks of 54 %, < 34 weeks of 43% and 15% for < 28 weeks 
GA. This contrast may be due to the high-risk profile of our cohort influenced by a 
high smoking prevalence, older maternal age, one in four women having pre-
existing medical disorders and the previous obstetric history. Furthermore, our 
study had a mixed miscarriage profile for the HI cerclage group, with only 51% 
having a typical history of cervical incompetence. This may have influenced our 
PTB rates as reported in the RCOG study where the effect of cervical cerclage was 
only seen in a subset of women with three or more second trimester pregnancy 
losses.  
 
The ultimate aim of cervical cerclage insertion is to reduce perinatal mortality and 
morbidity from prematurity through reduction of PTB. This is best reflected in the 
reported live birth and perinatal loss rates. Literature identified for live birth and 
perinatal loss rates for HI cerclages are limited to only 2 trials. Both these studies 
reported a live born rate of approximately 93% and a perinatal loss rate of 9%.17,19 
In comparison, the slightly lower live born rates reported in our study of 85% in the 
HI group, might primarily be attributed to the higher early pregnancy loss and 
PPROM rates. This is again a clear reflection of the high-risk profile and multiple 
comorbidities observed in this cohort. 
 
For UI cerclages, the first evidence comes from a small study by Althuisius 44 in 
which 35 women with risk factors for cervical incompetence and a TVUCL of < 
25mm were randomised to cervical cerclage insertion or bed rest. In this study 
cerclage insertion group, there were no PTB before 28 weeks of gestation, and the 
PTB rate before 37 weeks GA was 21%. While in the bedrest group the PTB rate 
before 28 weeks was 19% and the PTB rate before 37 weeks GA was 63%.  A 
subsequent study targeting high risk women by Berghella et al.,27 randomised 61 
women to a cervical cerclage or bed rest when the TVUCL was less than 25mm. 
Here the reported PTB rates for < 37 weeks GA and <34 weeks GA were 52% and 
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42% respectively in the cerclage group. On the other hand the PTB rate in the bed 
rest group for <37 weeks and < 34 weeks GA were 64% and 50% respectively. 
However these findings should be treated with caution as this final study population 
was a combination low risk and high-risk women including twins.27 The largest RCT 
study targeting high risk women with TVUCL screening was done by Owen et al.46 
In this multicentre trial 302 women were randomized to a cervical cerclage insertion 
or standard care after they had a TVUCL < 25mm. Here the reported PTB rates 
before 37 and 34 weeks’ GA were 45% and 28% respectively in the cervical 
cerclage group. While in the standard care group the PTB rates <37 weeks and 
<34 weeks GA were 59% and 37 %. Interestingly, the multicentre RCT reported by 
TO et al.,22 targeting all women at routine screening with a TVUCL of 15mm or 
less, reported a lower PTB rate before 33 weeks’ GA of 26% in the cervical 
cerclage group and 37% in the control group. Our data reflects the trend of a high-
risk population as in the publication of Owen et al., with our reported PTB rate 
before 37, 34 and 28 weeks’ GA of 55%, 33% and 20% respectively in the UI group. 
This is expected as our women in the UI group only qualified for serial TVUCL if 
they had a high risk obstetric history of PTB in combination with a TVUCL <25mm. 
These trends, although slightly higher, are comparable and also in keeping with 
another meta-analysis by Berghella et al.,24. In this met analysis the PTB rate 
before 35 weeks GA was 28% in the cerclage group compared with 41 % in the no 
cerclage group. 
 
The reported live birth rates of UI cerclages, from the above mentioned 
international studies in developed countries, range from 88-100%,44,22 which are 
higher compared to our study results of 77% in the UI group. This could be 
explained by the heterogeneity of the so called high risk profile inclusion criteria for 
TVUCL screening in the international studies. These included a spectrum of high-
risk profile patients with previous cold knife conisations, diethylstilbestrol exposure, 
to women with repeated PPROM history. On the other hand our study case 
selection for UI was based primarily on a history of preterm birth or MTL and 
shortening midtrimester cervix of <25mm. In addition, our study profile is clearly 
that of a high-risk group due to a complexity of variables including maternal 
comorbid as well as pregnancy related factors.  
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When reflecting on the PTB rate comparison between the HI and UI groups in our 
study, outcomes at first appear to be similar, PTB rate before 37 weeks’ GA was 
around 54% in both groups. However, a difference is noted in the PTB rates 
specifically before 34 weeks’ GA with higher rates in the HI group (43% in HI and 
33% in UI group). This difference before 34 weeks GA could be explained by the 
obstetrical risk profile in the HI group which was much ‘worse’ with higher 
incidences of recurrent T2 miscarriages. A paradoxical trend of a higher rate for 
PTB rate before 28 weeks’ GA was seen in the UI group (15% in HI group and 20% 
in UI group) but the numbers were small and very difficult to interpret whether this 
trend reflects any clinical importance. 
 
The previously mentioned meta-analysis by Berghella et al.,45 also noted similar 
PTB rates with no clear differences in deliveries before 37weeks GA (31% in both 
HI and UI cerclage groups) but a higher rate of PTB before 34 weeks’ GA in HI 
cerclages (23% in HI vs. 17% in UI cerclages). As a result of these findings, 
Berghella concluded that those women with a singleton pregnancy and previous 
history of PTB can safely be monitored with serial transvaginal ultrasound, and a 
cervical cerclage inserted in the women with a shortening cervix compared to policy 
of routine HI cerclage. When reflecting on PTB rates <34 weeks’ GA our study 
supports this conclusion. However not all centres may have the manpower, skill 
and equipment to carry this out especially in a developing country. Nevertheless, 
when reflecting on the higher live birth rates in the HI group, targeted screening 
with appropriate history taking will remain a corner stone for HI indicated cerclages 
to reduce the morbidity and mortality associated with PTB in a resource restricted 
country.  
As for CI cerclages, a recent systemic review and meta-analysis included 10 
studies of which only one was a RCT and reported a PTB rate in the cerclage group 
of 50% and 8% before 34 and 28 weeks’ respectively.47 Although it was stated that 
the quality of the included studies was limited, this remains the best data to date. 
In our study, all CI cerclages delivered before 28 weeks’ gestation. Unfortunately, 
we do not have placenta histology which may have assisted in determining the 
causes of PTB in some of the cases. The findings do emphasise that CI cerclage 
should only be considered in carefully and appropriately selected patients. Even if 
multiple risk factors can be identified in our CI group the numbers were too limited 
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to draw any firm conclusions. There is a need to diligently assess the outcomes of 
CI cerclages in specifically resource restricted settings and critically evaluate all 
cases that qualify for CI cerclage. 
Fetal and neonatal outcomes for CI cerclage are inconsistently reported in 
literature.48 The systematic review mentioned earlier reported a neonatal survival 
of 71%,47 with individual studies reported an average neonatal survival rate of 
about 60%.49,50 The low live born outcome of 22% in our study is explained by the 
high miscarriage rate and extreme premature GA at delivery. 
 
Overall, in our study the spontaneous vaginal delivery rate (77%) and caesarean 
section (23%) rate were in keeping with published data on cervical cerclage 
outcomes.60 The latest Cochrane review on cervical cerclage for prevention of 
pregnancy loss in women reported an overall caesarean section rate of 18%, with 
specific rates of 14% and 28% reported for HI and UI groups.51 52 Our study’s 23% 
caesarean section rate is also comparable with the South African national and local 
provincial caesarean rate of about 25%.53 While the Cochrane collaboration review 
stated that Caesarean section rates are higher after cervical cerclage insertion, the 
background risk profile of the population should be taken into consideration. Lastly, 
14.3% (20/140) of the deliveries in our study were either induced or underwent pre-
labour caesarean section. This highlights the high rate of pregnancy related 
complications in this cohort, which has directly influenced the lower spontaneous 
vaginal delivery rate.  
  
5.3 Population risk profiles 
It is well established that a detailed history, physical assessment and TVUCL scan 
are the corner stones for the appropriate management of patients with potential 
cervical incompetence. The risk profile of a patient can be altered due to countless 
factors that in turn can influence the outcome. As in this cohort there have been 
several observations on differences in patient demographic profile between 
developing and developed countries.7 These differences have been attributed to 
ethnic variations, social factors such as poverty, behavioural patterns, early sexual 
debut and intrinsic biological factors.7 The majority of our study population are of a 
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low socioeconomic status that could explain some issues surrounding difficulty in 
health care access, health education as well as the high recreational drug use.  
 
Another major comorbidity of our time, obesity, was common in our study (29%). 
Farinelli et al., clearly noted an association between increasing BMI and earlier GA 
at delivery in women undergoing UI cervical cerclage insertion.54 However, this 
result was driven by several women with a BMI >47 kg/m2 and overall obesity had 
no significant effect on the gestational age of delivery in the cervical group. A 
subsequent systematic review on this topic, concluded that obesity did not affect 
the gestational age of delivery in women with cervical cerclage but due to small 
numbers and methodological heterogeneity no firm deduction could be made. 55 In 
our cohort BMI definitely added to the risk profile of the groups but was not 
independently associated with a difference in stitch interval or cerclage success. 
 
Several maternal risk factors are known to be associated with recurrent pregnancy 
losses and PTB. These include smoking, maternal infections, hypertensive and 
autoimmune disorders among others.7 The high South African national and local 
provincial smoking prevalence of 18% and 32% respectively are reflected in our 
cohort.56 This is similar to an American publication57 but significantly higher than 
other publications from  Africa5. This high smoking prevalence maybe a significant 
confounding factor in our reported outcomes as smoking is a known risk factor for 
PTB.58 South Africa is also known to have one of the highest prevalence of 
hypertension in the world and chronic hypertension is a well-known risk factor for 
preterm delivery.59,60 Unfortunately, this is not well reported in other cervical 
cerclage studies and therefore we cannot comment on the differences of chronic 
comorbidities between cervical cerclage studies. Yet, the overall incidence of 
chronic hypertension of this cohort (12%) must have played a role in the perinatal 
outcomes.  
Therefore, the presence of each or a combination of the above risk factors already 
places the patient at high risk of PTB and could have significantly influenced our 
study PTB outcomes. Hence pre-pregnancy counselling and management of these 
risk factors in any population setting is of paramount importance to improve any 
obstetric outcome. 
 
Stellenbosch University  https://scholar.sun.ac.za
35 
 
5.4 Cases selection and management 
Although it was clear that the background history from our study was filled with 
multiple pregnancy losses and PTB, it was extremely difficult to obtain a clear 
history and to establish the exact order of events. As in our study where after record 
review only 51% of our HI cerclages were deemed to have a classic history of 
cervical insufficiency. This could potentially have resulted in unnecessary 
interventions and potential harm in the those who had an unnecessary HI cerclage 
insertion as stated by Althuisius.44 It is therefore crucial that a detailed history is 
obtained during the screening process, especially for HI cerclages. This can be 
facilitated by clear documentation and proper discharge notification with adequate 
patient education after a poor obstetrical outcome. In cases where there is an 
unclear miscarriage profile or PTB history, close follow up with serial transvaginal 
ultrasound could be advocated.45  
 
The importance of a thorough structural fetal assessment through a dedicated 
ultrasound service cannot be overstated. Many developed countries have routine 
services that reaches all women and ensures accurate gestational age 
determination and early structural abnormality identification. Unfortunately, many 
developing countries lack basic ultrasound facilities as reflected in the Kenyan 
study where the majority of women (66%) had no ultrasound examination 
beforehand.5 This makes it difficult to identify high risk patients and institute early 
management. Even in our cohort a fetus with T18 was noted only at the routine T2 
scan after a HI cerclage was already inserted at 14w. This could have been 
potentially been picked up with a policy of routine first trimester screening.61  
 
In our cohort, UI cerclages were only placed in high-risk women with previous 
spontaneous PTB and MTL, in combination with shortening midtrimester cervical 
length as in the study of Owen et al.21 This selective high-risk profile screening 
program is preferred to universal cervical length screening program as 
demonstrated in the study done by Shinker et al. In this study universal cervical 
length screening programs in low risk women lead to an increase in antenatal 
interventions, increase cost and no reduction in PTB rates.62 Despite initial positive 
evidence for an universal screening program63 follow up studies show less robust 
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evidence for it use62 64 and reduced acceptability by clients65. 
Unlike the heterogeneity of the HI cerclage group the UI group had a good case 
selection, appropriate TVUS and timely cervical cerclage insertion. However, there 
are challenges faced with implementation of a good cervical length screening 
program in resource restricted settings. A crucial influencing factor is the skill of the 
ultrasonographer and the process of quality control. This has impact on the quality 
and reproducibility of any cervical length assessment.66 Boelig et al.,66 reported up 
to 15% of qualified trained sonographers failed to produce reproducible cervical 
length assessment images. Furthermore, patient’s acceptability for TVUS is also a 
challenging factor, as observed by Ghartey et al.,65 where multigravida, African 
American, smoking, obese and older women were more likely to decline TVUCL. 
This patient profile is similar to our cohort however there is a need for local and 
African based studies to identify patient related limiting factors to TVUCL 
screening. Another major factor is the cost and availability of ultrasonography as 
reported in the previously mentioned Kenyan study where only 34% had an 
ultrasound scan for cervical length assessment, and 7.8% received a transvaginal 
ultrasound.5 
 
As for CI cerclages, the biggest challenge lies within selecting the most appropriate 
candidates. Our data is limited in numbers but already from this small series the 
complexity of how they present can be appreciated. A great concern, especially in 
this group, is missing those with an established amniotic fluid microbial invasion. 
This is supported by evidence from a study where Romero et al., in which amniotic 
fluid microbial invasion was identified in >50% of women with acute cervical 
insufficiency and cervical dilatation of >2 cm.67 This invasion can lead to subclinical 
intraamniotic infection (IAI) and has been reported in up to a third of patients being 
screened for CI cerclage.68,69 However, there is currently no consensus on routine 
amniocentesis use, and the safety and efficacy of amniocentesis prior to citing a 
CI cerclage. In this cohort, no amniocentesis was performed to rule out infection 
beforehand and it could be debated whether this would have resulted in better case 
selection. However, there is strong enough evidence to perform an amniocentesis 
in cases with already suspected subclinical IAI prior to placement of an  CI 
cerclage.70  
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Different strategies have been used and reported with regards to perioperative 
tocolysis antibiotics use. Generally, their use is not uniformly reported and 
therefore there are no current standardised regimes that can be reviewed. For 
women undergoing HI cerclage, when the cervix is not short or dilated, the use of 
prophylactic antibiotics is not indicated.71 The same can be advised for women 
undergoing UI cerclages. Although four RCTs have reported on the use of 
perioperative antibiotics in UI cerclages, due to the study structures no separate 
assessment on efficacy of such an intervention was done.46,44,22 Only in one 
secondary analysis of a multicentre trial was antibiotic use associated with a 
prolonged gestation but this was not superior to the no treatment arm nor was there 
a finding of any one specific antibiotic regime superior to another.72  
Therefore, currently for both HI and UI cerclages routine prophylactic antibiotics 
are not endorsed.11 For women undergoing CI cerclage the role of perioperative 
antibiotics is unclear and definitely dependant on the risk profile of the women. 
Several trials have used prophylactic antibiotic regimes for extended periods but 
no separate analysis evaluated the efficacy of such co-management 
strategies.73,74,50 Another small retrospective and poorly controlled study has 
suggested benefit of antibiotics but the evidence is insufficient to make such a 
recommendation.75 In our cohort, a uniform regimen of prophylactic perioperative 
antibiotics was used in the majority of cases. However, as with PTB prevention in 
asymptomatic women antibiotics should best not be used as benefit appears 
limited and a real possibility of harm with unscrupulous use does exist.76  
 
As with perioperative antibiotic use, evidence for use of tocolytic agents is also 
limited especially in asymptomatic women undergoing HI cerclage. For women 
undergoing UI cerclage, one retrospective study reported no difference with the 
use of perioperative indomethacin.77 Once again, the same conclusion was made 
in a retrospective study evaluating the role of indomethacin in CI cerclages.78 
Therefore, as for antibiotics, perioperative tocolysis is not currently endorsed due 
to the lack of prospective data and retrospective data indicating no significant 
benefit.11 Lastly, although neither of the above strategies has been proven 
efficacious on their own, their combined use has been recently reported in a 
RCT79.The the combined use of broad spectrum antibiotics and indomethacin in 
this RCT lead to a longer gestational latency, but no difference in the GA at delivery 
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or neonatal outcomes in CI cerclages. In our cohort, close to 80-90% of all cases 
received both perioperative antibiotics and indomethacin and this practice needs 
to be re-evaluated. In addition the use of routine preoperative cervical cultures has 
not been shown to be beneficial in women undergoing cerclage either.70 
 
5.5 Minimizing the procedure related costs and complications 
Current practices are moving towards adopting UI cerclage policies and away from 
HI cerclage, as evidence for its use is more robust, and points towards better 
outcomes.25 Evidence has also shown that women with a singleton pregnancy and 
previous history of PTB can safely be monitored with serial transvaginal ultrasound, 
with cervical cerclage inserted only in the women with shortening cervix compared 
to policy of routine HI cerclage.11 This may then avoid over half of unnecessary HI 
cerclage insertions reducing long term costs, operative risks and complications. In 
our study, HI and UI cerclages had similar success rates of 81% and 76%, but in 
the UI group there were less deliveries before 34 weeks’ gestation (43 vs. 33%). 
In view of the above evidence presented and our study results, it can safely be 
concluded that a trend towards UI cerclage rather than HI cerclage insertion has 
the potential to yield better pregnancy outcomes. The increase use of TVUCL 
brings in the debate of universal cervical length screening of all pregnant women 
versus targeted high risk cervical length screening. Universal cervical length 
screening was initially recommended as a strategy to reduce PTB, through which 
patients with shortening cervical length are offered intervention of progesterone or 
cervical cerclage insertion80. This has brought in the issue of cost effectiveness. 
Although a RCT by Werner et al., in 201181 initially conclude that universal 
screening was cost effective the specific efficacy of such an approach remains 
debatable.82 It would require screening 100,000 women to prevent 10 neonatal 
deaths. Resulting in unnecessary procedures and interventions, anxiety and stress 
to the clients.83 Therefore, high risk TVUCL remains the best option, and there is 
robust evidence for it as discussed previously. It is of paramount importance that 
TVUCL are done with proper TVU technique with continuing quality assurance, 
single targeted screening gestation between 18 – 24 weeks and a cut off for 
intervention when TVUCL equal to or less than 25mm.80 In absence of these 
prerequisites the efficacy and cost effectiveness of this intervention is nullified. 
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Despite the evidence for UI cerclage the cost of ultrasound scan equipment, 
infrastructure, training of medical personnel, ineffective referral system may make 
implementation difficult in a developing country setting. This is especially 
challenging where provision of basic primary health care is already a problem. One 
possible feasible solution is setting up appropriate referral systems with expertise 
centres that could reduce the overall cost. 
 
The primary surgeon involved in placement of cerclage was mainly a qualified 
obstetrician. On the contrary other reports from developing countries such as 
Nigeria, the majority of the cerclages were placed by a senior registrar.48 There is 
a distinct advantage of having senior and especially skilled personnel to perform 
these procedures. This ensures the transfer of skill and correct placement of 
cervical cerclages with reduction of intraoperative and perioperative complications. 
Therefore, providing this skill in a reference centre will be more beneficial to the 
outcome, promote and retain specialised skills in the area and provide adequate 
data for research purposes.  
 
In order to assess the safety and efficacy of cervical cerclage insertion, or any 
intervention, a thorough understanding of the current management and outcomes 
are needed. This will direct urgent attention points and future research areas. In 
our study intraoperative cervical tears (2%), and cerclage displacement (5%) are 
definitely higher than the reported outcomes.54 Thorough physical examination 
during selection criteria and prior to cervical cerclage insertion is critical to plan 
appropriate surgery and reduce perioperative complications. Women with a very 
short cervix and especially a short vaginal portia may benefit from transabdominal 
cerclage rather than transvaginal cerclage insertion reducing the rate of 
displacement and cervical tears. In addition, an appropriate technique is required 
which can be achieved through diligent supervision and ensuring sufficient 
caseloads through dedicated service centres. Though our perioperative 
complication rate was much higher; a conclusive statement cannot be made and a 
prospective study may shed more light on this.  
 
PPROM is the most consistently reported complication in cervical cerclage 
outcomes. Our overall PPROM rate of 22% was in keeping with most reported 
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studies on either HI or UI cerclages. ACOG reports rates of 0.18-18% 11 and  Rush 
et al 17.7 % 19 for HI. Higher PPROM international rates are seen in the UI group,  
with ACOG reporting rates between  3-65.2%53  and Berghella et al 81 reports a 
rate of 35%. These high rates may be attributed to poor patient selection criteria, 
for example in some studies any patient with short cervix on TVUS had a cerclage 
inserted, whether high or low risk. The combination of medical and obstetric 
conditions as confounding factors could have easily influence the PPROM rate in 
reported literature as well this cohort. Reduction in PPROM rate would require 
revision of cerclage techniques and selection of cases.  
Higher rates of PPROM, around 20%, are also reported for CI cerclages84 and our 
reported 11% might be wrongly interpreted as a low rate. This ‘low rate’ in our study 
is mainly because all our patients in CI delivered before 28 weeks’ gestation and 
majority ended up delivering before 24 i.e. being labelled as miscarriages. Most 
likely PPROM rate in our study was attributed to the predisposition to PTB rather 
than cervical cerclage insertion itself. Yet the selection of cases strongly influence 
these rates and several clinical factors have already been identified.85 Furthermore 
an initial observation period of 24 hours to ensure the absence of any uterine 
contractions have shown to improve outcome.84 Therefore in resource restricted 
settings a simple observation period with diligent clinical review could lead to better 
selection and outcomes in CI cerclage. 
 
Other strategies that have been reported on to improve the efficacy of cervical 
cerclage include the type of suture material and needle, cervical cerclage modified 
techniques and hospitalisation but no clear benefit of one over another have been 
shown.70  
 
5.6 Limitations of the study 
Firstly, the limitation of being a retrospective study must be considered. Notably 
this study suffered from patient and treatment selection bias. Just under 10% of 
identified cases could not be analysed due to missing records and another 16% of 
cases were analysed but did not have complete records. Absence of data on 
potential confounding factors may have caused a significant observer bias. Another 
major limitation of this study was the difficulty in collection of neonatal data mainly 
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because the majority of the maternal case folders were not linked to the neonatal 
files. Lastly, only a very small CI group was identified due to problematic theatre 
registrations and therefore this study does not reflect all the CI cases performed.  
 
5.7 Strength of the study 
This study provides current data in a real world developing country setting. It is well 
sized and comparable to other retrospective observational studies from developing 
countries 86  especially African5 countries. The true strength of the study is the 
detailed antenatal clinical review with specific cerclage related complications and 
categorised delivery outcomes. 
 
5.8 Conclusions and future directions 
Cervical cerclage insertion remains a cornerstone in the prevention of PTB 
especially in high risk populations. In our study both HI and UI cerclages had good 
success and live born rates, with the outcomes of UI cerclage being comparable 
to international evidence. Regrettably CI cerclages had poor outcomes but specific 
variables were difficult to identify due to the complex high-risk nature of this cohort.  
This study reflects the specific needs of a developing country where the correct 
identification of eligible women for cerclages are difficult, and that CI cerclages 
should preferably be done in a clinical research setting.  
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Appendices 
 
 
  
Study Code Nr: Cerclage Outcome Study - Confirm that this is a singelton     Y/N
Descriptive Key [Input Form] [Example] Input (Capital X for unknown)
EDD (from formal US) Date [cccc/mm/dd] [2011.11.11]
Age Number [x] [36]
G Number [x] [2]
P Number [x] [2]
Prev T1 MC <13w Number total and number of spont., unknown cause [x (x)] [2 (1)]
Prev T2 MC 13-23.6w Number total and number of spont., unknown cause - LB/FSB [x (x)] [2 (1)]
Prev 13-23.6 SFP losses 0 Nil then 1,2,3 etc. [x] [2]
Prev PTB 24-27.6w Number total and number of spont., unknown cause - LB/FSB [x (x)] [2 (1)]
Prev PTB 28-33.6w Number total and number of spont., unknown cause - LB/FSB [x (x)] [2 (1)]
Prev PTB 34-36.6w Number total and number of spont., unknown cause - LB/FSB [x (x)] [2 (1)]
Living Children Number [x] [2]
Prev SGA (<2500g) Number [x] [2]
Prev Obs Hx 0 Nil, 1 GHT, 2 PreE, 3 Abruptio, 4 PPROM 5. Severe IUGR, [0]
6 Prolonged 2nd stage, 7 AVD, 8 Prev Curettage, 9 Other
Medical Hx 0 Nil, 1 CHT, 2 DM, 3 Epilepsy, 4 HIV, 5 Asthma, 6 Other [0]
Medication/Other Hx
Surgical Hx 0 Nil, 1 C-section, 2 Abdominal, 3 Gynae [0]
Cervical Surgery 0 Nil, 1 LLETZ/LEEP, 2 CONE, 3 Obs tear, 4 Other [0]
Substance use 0 Nil, 1 Smoking,  2 Alcohol, 3 Methamph, 4 Other drug use [1]
BMI (kg/m2) Number [xx,xx] [31,54]
Dipsticks 0 Neg, 1 PU ≥ 1+, 2 HU ≥ 1+, 3 GU ≥ 1+ [0]
RPR 0 Neg, 1 Pos and Rx, 2 Pos and not Rx [0]
HIV 0 Neg, 1 Pos on MTCT, 2 Pos on HAART [0]
Hb (g/dl) at booking Number [xx.x] [11,1]
MSU 0 No Growth, 1 ASB and Rx, 2 ASB not Rx [0]
NT Scan 0 No, 1 Yes, Normal; 2 Yes, High Risk/Fetal Anomaly [1]
Anomaly Scan 0 No, 1 Yes, Normal; 2 Yes, High Risk/Fetal Anomaly [1]
Prev Cerclage 0 No, 1 McDx1, 2 McD>1, 3 TAC, 4 Shirodkar [0]
Successful (delivery ≥ 28.0w) 0 No, 1 Yes x1, 2 Yes x2, 3 Yes x3, 4 Yes x4 [0]
Cervix Clinical Eval Portio Vaginalis Shortest (mm) [15]
Old Tears/Trauma 0 No, 1 Yes [0]
Wetmount X Unknown; N Not Done; 0 Normal; 1 BV; 2 Trichomonas; 3 Chronic Cervicitis; 4 Other
CxL Screening (shortest mm) X Unknown; N Not done; length in mm [X or N or 11]
GA of Shortest CxL (ww.d) Number [xx.x] [18.6]
Cx Dilatation (mm) X Unknown; N not done, ND not dilated, or dilatation in mm [X or N or ND or 11]
Study Code Nr: Cerclage Outcome Study - Confirm that this is a singelton     Y/N
Assessor's Final Diagnosis 1 Recurrent MC, 2 Recurrent MTL,  3 Cx Incompetence (Hx),
 4 Short CxL in high risk case (US Indicated); 5 Clinical Incompetence (Rescue Cerclage)
Date of Cerclage Date [cccc/mm/dd] [2011.11.11]
Gestation of Cerclage (ww.d) Number [xx.x] [18.6]
Procedure indication from file 1 McD Hx Indicated, 2 McD US Indicated, 3 McD Rescue/Emergency, 4 Other [1]  
Preop or immediate postop Rx 1 Oral Ab, 2 IV Ab, 3 Nifedipine, 4 Indomethacin [1]
Surgeon 1 MFM Team, 2 Consultant, 3 Sr Reg, 4 Jr Reg, 5 MO [1]
Surgery Time (min) Number [xxx] [19]
Suture Material X Unknown; 1 Mers. tapercut; 2 Mers. blunt; 3 Mers. Other; 4 Nylon cut; 5 Polypropylene tapercut; 6 Other 
Surgical complications 0 Nil, 1 Cx Tear, 2 Inability to place, 3 PVB, 4 ROM, 5 Other [0]
Notes
Anaesthesia 0 Sedation, 1 Spinal, 2 Epidural, 3 GA [1]
Post-op TV US X Unknown; N Not done; length in mm [X or N or 11]
Post op hospital stay (days) Number [xx] [1]
Cerclage Complications (After DC) 0 Nil, 1 Displacement/Slipped, 2 PVB, 3 ROM (any gest), 4 Other [1]
Other
Antenatal Complications 0 UnCompl, 1 MC, 2 PTL, 3 PPROM, 4 APH, 5 GHT, 6 PreE, 7 GDM, 8 IUGR, 9 Other
Antenatal Admission Number 0 Nil then 1,2,3 etc. [x] [2]
Antenatal Admission Days (total) Number [xx] [7]
Tocolysis (Antenatal) 0 No, 1 Yes (once), 2 Yes (more than once), 3 Yes (note total hours) [1]
Tocolysis (Antenatal) 0 Nil, 1 Indomethacin, 2 Nifedipine, 3 Salbutamol
Antenatal Steroids 0 No, 1 Yes (1 course), 2 Yes (2 Courses), 3 Yes (>2 courses) [1]
Suture removal 1  Predelivery, 2 At delivery, 3 After delivery [2]
Suture removal gestation (ww.d) Number [xx.x] [28.6]
Date of Delivery Date [cccc/mm/dd] [2011.11.11]
Delivery Gestation (ww.d) Number [xx.x] [28.6]
Labour Onset 1 Spontaneous, 2 Indicated (planned IOL), 3 Indicated (planned CS) [1]
Delivery mode 1.Caesarian Section 2.Vaginal Delivery [2]
Caesarean Indication
Gender 1 Male, 2 Female [x] [1]
Neonatal Outcome 1. Alive, 2 FSB, 3 MSB, ENND [x]
Outcome Weight (g) Number [xxxx] [1171]
Outcome APGAR (5min) Number [xx] [7]
Outcome CBG (pH) Number [x,xx] [7.19]
Neonatal Admission to NICU 0 No, 1 Yes [x] [1]
Neonatal Complications 0 Nil, 2 Septicaemia, 3 IVH, 4 BPD, 5 NEC [1]
Placenta Weight (g) Number [xxx] [400]
Placenta Clinical Description 0 Nil, 1 Infarcts, 2 Abruptio, 3 ChorioAmn [x] [x] [1]
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